All News

Integra LifeSciences Announces Leadership Transition

Stuart M. Essig, chairman of Integra’s Board of Directors, has been appointed president and chief executive officer, effective May 1, 2026. Mr. Essig will continue to serve as chairman. He succeeds Mojdeh Poul who is pursuing other opportunities. Integra also announced that Michael McBreen, currently executive vice president, president, Codman Specialty Surgical, has been appointed chief commercial officer.

Integra LifeSciences Reports First Quarter 2026 Financial Results

Integra LifeSciences reported financial results for the first quarter ending March 31, 2026.

World Health Starts with Innovation

Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization

Maria Cristina Fernandez-Gonzalez Named a 2026 Luminary by Healthcare Businesswomen’s Association (HBA)

A Steady Hand Behind Every Event

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results

Integra LifeSciences reported financial results for the fourth quarter and full year ended December 31, 2025.

Integra LifeSciences Announces Key Executive Leadership Appointments

Purpose in Motion: Turning Integrity into Impact

Restoring Lives Beyond the Operating Room

The following is an excerpt from a Q&A with Malachy Asuku, MD, FACS, MBA. From his background as a reconstructive surgeon in the operating room to his current role as medical director for Integra’s Wound Reconstruction & Care portfolio, he is innovating for outcomes through science, strategy, and a deep commitment to transforming patient care.

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

Live Quality

For World Quality Week, we’re proud to spotlight Ken Sousa, principal manufacturing engineer and workstream lead for design transfer for the enterprise compliance master plan. Ken is based in our Billerica, Massachusetts site.